SPHERA FUNDS MANAGEMENT LTD.
CIK 1496201 · last filed 2021-05-04
SPHERA FUNDS MANAGEMENT LTD. is a corporate insider who has filed 7 SEC Form 4 insider transactions across 2 companies since 2010. The most recent filing, for HOWL, was dated May 4, 2021. Across all open-market trades the lifetime net is +$7.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $779.9K across reported positions. The firm reports its address in Tel Aviv, L3. 17 SEC filings were submitted jointly with Israel Mor.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
HOWL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
29TH FLOOR
TEL AVIV, L3 6777520
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HOWL | 10%+ Owner | 787,997 | $0.99 | $779.9K | $7.60M | 1 | 2021-05-04 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | 57,188 | — | — | -$83.0K | 1 | 2010-08-16 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-04 | HOWL | Mixed | +787,997 | $7.60M | EDGAR |
| 2011-06-23 | — | Sell (S) | −399,002 | -$1.25M | |
| 2011-06-20 | — | Sell (S) | −399,002 | -$1.25M | |
| 2011-06-02 | — | Sell (S) | −11,000 | -$27.0K | |
| 2011-03-30 | — | Sell (S) | −12,316 | -$50.1K | |
| 2011-03-25 | — | Sell (S) | −33,800 | -$135.4K | |
| 2010-08-16 | Orexigen Therapeutics, Inc. (OREX) Delisted | Sell (S) | −20,000 | -$83.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.